Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q2 2026 Earnings

29AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.02
0.08
0.14
0.2

Details

Expected EPS
0.12492673241399999
Actual EPS
0.14514214911372
Surprise EPS
0.02
Surprise Percent
+16.18%

Description

Shenzhen Hepalink Pharmaceutical Group. (9989.HK) has reported earnings of 0.14514214911372 per share for Q2 2026.

0 Comments

Share your thoughts